Tachykinin-eicosanoid crosstalk in airway inflammation

Trends in Pharmacological Sciences

Volumn 21, Issue 9, 2000, Pages 336-340

  Montuschi, Paolo ^a   Preziosi, Paolo ^a   Ciabattoni, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANTIGEN; ICOSANOID; LEUKOTRIENE C4; LEUKOTRIENE E4; LEUKOTRIENE F4; NEUROKININ 2 RECEPTOR; NEUROKININ A; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN SYNTHASE; SUBSTANCE P; TACHYKININ; THROMBOXANE A2;

ANAPHYLAXIS; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ASTHMA; BRONCHOSPASM; CONTROLLED STUDY; GUINEA PIG; HYPERSENSITIVITY; MAST CELL; MEDIATOR RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSITIZATION; SHORT SURVEY;

EID: 0034284273     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01520-0     Document Type: Note

References (45)

1. Barnes P.J. Pathophysiology of asthma. Br. J. Clin. Pharmacol. 42:1996;3-10.
2. 1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea pigs. Am. J. Respir. Crit. Care Med. 159:1999;423-430.
3. Lindstrom E.G., Andersson R.G.G. Neurokinin A-LI release after antigen challenge in guinea-pig bronchial tubes. influence of histamine and bradykinin Br. J. Pharmacol. 122:1997;417-422.
4. Bertrand C.et al. Involvement of neurogenic inflammation in antigen-induced bronchoconstriction in guinea pigs. Am. J. Physiol. 265:1993;L507-L511.
5. O'Byrne P.M.et al. Late asthmatic responses. Am. Rev. Respir. Dis. 136:1987;740-751.
6. 2 receptor antagonist, SR 48968, of antigen-induced airway hyperresponsiveness in sensitized guinea-pigs. Br. J. Pharmacol. 114:1995;259-261.
7. 2 tachykinin receptor antagonist SR 48968 (saredutant) on the neurokinin A-induced bronchoconstriction in asthmatics. Eur. Respir. J. 12:1998;17-23.
8. Drazen J.M.et al. Treatment of asthma with drugs modifying the leukotriene pathway. New Engl. J. Med. 340:1999;197-206.
9. Ciabattoni G.et al. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung. Br. J. Pharmacol. 109:1993;243-250.
10. Morrow J.D.et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free-radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U. S. A. 87:1990;9383-9387.
11. 2α in vitro and in vivo via the cyclooxygenases. J. Pharmacol. Exp. Ther. 282:1997;1658-1665.
12. 2α, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am. J. Respir. Crit. Care Med. 153:1996;590-596.
13. 4. Exp. Lung Res. 16:1990;645-659.
14. 4, and substance P from guinea pig lungs. Am. J. Physiol. 261:1991;L449-L455.
15. Kohrogi H.et al. Inhibition of neutral endopeptidase potentiates bronchial contraction induced by immune response in guinea pigs in vitro. Am. Rev. Respir. Dis. 144:1991;636-641.
16. Tudoric N.et al. Inhibition of neutral endopeptidase augments anaphylactic constriction of guinea pig tracheal smooth muscle. Int. Arch. Allergy Immunol. 100:1993;170-177.
17. 4-induced airway responses. Eur. Respir. J. 9:1996;486-492.
18. Ellis J.L., Undem B.J. Role of peptidoleukotrienes in capsaicin-sensitive sensory fibre-mediated responses in guinea-pig airways. J. Physiol. 436:1991;469-484.
19. McAlexander M.A.et al. Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway. J. Pharmacol. Exp. Ther. 285:1998;602-607.
20. 4 and antigen-induced contraction of guinea pig isolated bronchus. J. Pharmacol. Exp. Ther. 283:1997;1102-1109.
21. 4 in normal and asthmatic subjects. Eur. Respir. J. 7:1994;459-466.
22. Tudoric N.et al. Phosphoramidon modulates effects of the 5-lipoxygenase inhibition on anaphylactic contraction of the guinea pig trachea. Int. Arch. Allergy Immunol. 103:1994;293-297.
23. Tocker J.E.et al. Vagal stimulation augments pulmonary anaphylaxis in the guinea pig lung. Am. J. Respir. Crit. Care Med. 151:1995;461-469.
24. 2 receptor antagonists decrease eicosanoid release in lung anaphylaxis. Eur. J. Pharmacol. 313:1996;R1-R3.
25. 2α release from guinea-pig lung in vitro. Eur. J. Pharmacol. 365:1999;59-64.
26. Montuschi P.et al. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am. J. Respir. Crit. Care Med. 160:1999;216-220.
27. Dworski R.et al. Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics. Am. J. Respir. Crit. Care Med. 160:1999;1947-1951.
28. Selig W.M.et al. Pharmacologic modulation of antigen-induced pulmonary responses in the perfused guinea pig lung. Am. Rev. Respir. Dis. 147:1993;262-269.
29. Tamaoki J.et al. IgE-dependent activation of alveolar macrophages augments neurally mediated contraction of small airways. Br. J. Pharmacol. 103:1991;1458-1462.
30. Smith J.A.et al. Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Br. J. Pharmacol. 124:1998;513-523.
31. Weinreich D., Wonderlin W.F. Inhibition of calcium-dependent spike after-hyperpolarization increases excitability of rabbit visceral sensory neurones. J. Physiol. 394:1987;415-427.
32. Gold M.S.et al. Hyperalgesic agents increase a tetrodotoxin-resistant sodium current in nociceptors. Proc. Natl. Acad. Sci. U. S. A. 93:1996;1108-1112.
33. Brunelleschi S.et al. Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. Br. J. Pharmacol. 107:1992;964-969.
34. Benyon R.C.et al. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br. J. Pharmacol. 97:1989;898-904.
35. Maggi C.A. The effects of tachykinins on inflammatory and immune cells. Regul. Pept. 70:1997;75-90.
36. 2 tachykinin receptor-mediated responses in vagal afferents. Am. J. Respir. Crit. Care Med. 161:2000;232-236.
37. Undem B.J.et al. Allergen-induced sensory neuroplasticity in airways. Int. Arch. Allergy Immunol. 118:1999;150-153.
38. Stead R.H.et al. The innervation of mast cells. Freier S. The Neuroendocrine-Immune Network. 1990;19-37 Boca Raton.
39. Joos G.F., Pauwels R.A. The in vivo effect of tachykinins on airway mast cells of the rat. Am. Rev. Respir. Dis. 148:1993;922-926.
40. Kiernan J.A. Degranulation of mast cells in the trachea and bronchi of the rat following stimulation of the vagus nerve. Int. Arch. Allergy Appl. Immunol. 91:1990;398-402.
41. Joos G.F.et al. Role of 5-hydroxytryptamine and mast cells in the tachykinin-induced contraction of rat trachea in vitro. Eur. J. Pharmacol. 338:1997;259-268.
42. Suzuki R.et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J. Immunol. 163:1999;2410-2415.
43. 2 tachykinin receptors and their involvement in histamine release in a murine mast cell line. Neuropeptides. 21:1992;65-72.
44. Joos G.F., Pauwels R.A. Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases? Trends Pharmacol. Sci. 21:2000;131-133.
45. 2 from rat intrapulmonary bronchi. Am. J. Physiol. 275:1998;L1006-L1012.